Cover Image

60 minutes. An end in sight /

Show other versions (75)

A report on Pfizer's release of the first U.S. approved coronavirus vaccine. Created in collaboration with BioNTech, the vaccine has been expeditiously vetted through the design and certification process to meet the urgent need to stop the virus. Includes interviews with Kathrin Jansen, head of...

Full description

Bibliographic Details
Other Authors: Lieberman, Marc E. (Producer), Whitaker, Bill, 1951- (Interviewer)
Format: Video
Language:English
Language Notes:In English.
Published: New York, NY : Columbia Broadcasting System (CBS), 2020.
Series:60 Minutes
Subjects:
Pfizer Inc.
COVID-19 Pandemic, 2020-
COVID-19 (Disease)
COVID-19 vaccines.
Pandémie de COVID-19, 2020-
COVID-19.
Vaccins contre la COVID-19.
Television news programs.
Téléjournaux.
Online Access:Connect to this streaming video (Alexander Street Press)
Description
Summary:A report on Pfizer's release of the first U.S. approved coronavirus vaccine. Created in collaboration with BioNTech, the vaccine has been expeditiously vetted through the design and certification process to meet the urgent need to stop the virus. Includes interviews with Kathrin Jansen, head of vaccine research and development for Pfizer; Dr. Ugur Sahin and Dr. Ozlem Tureci, founders of BioNTech; Albert Bourla, Pfizer's CEO; and Dr. Mark Mulligan, director of the NYU-Langone vaccine center.
Physical Description:1 online resource (14 minutes)
Playing Time:00:13:26